GO:0006001 fructose catabolic process: Pathway, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0006001 fructose catabolic process describes the biochemical reactions that break down fructose, a ketohexose, into smaller metabolites.
• The small intestine is a major site of fructose catabolism, converting dietary fructose into glucose and organic acids before it reaches the liver.
• Hepatic fructose catabolism bypasses the phosphofructokinase regulatory step, fueling de novo lipogenesis and contributing to fatty liver disease.
• Fructose catabolism is reprogrammed in cancer cells to support nucleotide synthesis and redox balance.
• Excessive fructose catabolism impairs mitochondrial function in neurons and reduces healthspan in model organisms.
• Key enzymes include fructokinase (KHK), aldolase B (ALDOB), and triokinase (TKFC), which are critical for metabolic flux.
Description
Fructose catabolic process (GO:0006001) is the set of biochemical reactions that degrade fructose, a ketohexose, into downstream metabolites such as glucose, lactate, and organic acids. This pathway is essential for dietary fructose utilization and is conserved from mammals to model organisms. Unlike glucose, fructose enters glycolysis bypassing the phosphofructokinase regulatory step, allowing rapid flux that can drive lipogenesis and metabolic stress. The small intestine plays a dominant role in fructose catabolism, shielding the liver from excessive fructose exposure. Dysregulation of fructose catabolism is linked to metabolic syndrome, fatty liver disease, cancer, and neuronal dysfunction. Understanding this process at the molecular level is therefore critical for developing targeted therapies and for interpreting metabolic phenotypes in CRISPR-edited models.
fructose catabolic process At A Glance
| GO ID | GO:0006001 |
|---|---|
| GO term | fructose catabolic process |
| Ontology | biological_process |
| Synonym | fructose breakdown, fructose catabolism, fructose degradation |
| Major function | Breakdown of fructose into glucose, organic acids, and glycolytic intermediates |
| Key tissues | Small intestine, liver, kidney, adipose tissue |
| Key enzymes | KHK, ALDOB, TKFC, PFKL |
| Associated diseases | Metabolic syndrome, fatty liver disease, cancer, neurodegeneration |
What Is GO:0006001?
According to the Gene Ontology, fructose catabolic process (GO:0006001) is defined as the chemical reactions and pathways resulting in the breakdown of fructose, the ketohexose arabino-2-hexulose. This includes enzymatic steps that convert fructose into intermediates such as fructose-1-phosphate, glyceraldehyde, dihydroxyacetone phosphate, and eventually glucose, lactate, or organic acids. The term encompasses both canonical glycolytic breakdown and alternative metabolic routes that occur in different tissues, particularly the small intestine and liver.
Why Is fructose catabolic process Important in Cell Biology?
Fructose catabolism is central to energy homeostasis and metabolic disease. The small intestine catabolizes most dietary fructose, converting it to glucose and organic acids, which limits hepatic fructose exposure. When this intestinal barrier is overwhelmed, fructose reaches the liver, where its catabolism bypasses the regulatory step of glycolysis, promoting de novo lipogenesis and steatosis. In cancer, fructose catabolism supports proliferation by supplying nucleic acid precursors and maintaining redox balance. In neurons, excessive fructose catabolism impairs mitochondrial function and reduces healthspan. Thus, understanding GO:0006001 is essential for metabolic research and therapeutic targeting.
• Fructose catabolism in the small intestine determines systemic fructose exposure and protects against hepatic steatosis.
• Hepatic fructose catabolism drives de novo lipogenesis and contributes to non-alcoholic fatty liver disease.
• Cancer cells reprogram fructose catabolism to support nucleotide synthesis and antioxidant defense.
• Fructose catabolism in motor neurons impairs mitochondrial function and may contribute to neurodegeneration.
• Genetic defects in fructose catabolism cause hereditary fructose intolerance and fructose malabsorption.
• The pathway is a target for metabolic syndrome and type 2 diabetes interventions.
• Model organisms such as C. elegans are used to study fructose catabolism and healthspan.
• CRISPR screens can identify novel regulators of fructose catabolism in metabolic and cancer contexts.
What Happens During fructose catabolic process?
Intestinal fructose catabolism
In simple terms: The gut breaks down fructose before it reaches the liver.
The small intestine is the primary site of fructose catabolism, where dietary fructose is converted into glucose and organic acids such as lactate, acetate, and alanine. This process limits the amount of fructose that enters the portal circulation and reaches the liver. Intestinal fructose catabolism is rapid and can be saturated by high fructose loads, leading to increased hepatic exposure.
Hepatic fructose breakdown
In simple terms: The liver processes fructose into fat and energy.
In the liver, fructose is phosphorylated by fructokinase (KHK) to fructose-1-phosphate, which is then cleaved by aldolase B (ALDOB) into glyceraldehyde and dihydroxyacetone phosphate. These intermediates enter glycolysis or gluconeogenesis. Unlike glucose, fructose bypasses the phosphofructokinase regulatory step, allowing unchecked carbon flux that fuels de novo lipogenesis.
Fructose catabolism in cancer
In simple terms: Cancer cells use fructose to grow and survive.
Cancer cells often upregulate fructose catabolism to support rapid proliferation. Fructose-derived carbons feed into nucleotide synthesis and maintain redox balance through the pentose phosphate pathway. This metabolic reprogramming is observed in various cancers and is a potential therapeutic target.
Neuronal fructose catabolism
In simple terms: Nerve cells can break down fructose, but too much harms them.
Fructose catabolism occurs in neurons and can impair mitochondrial function when excessive. In mouse motor neurons and C. elegans, high fructose exposure leads to mitochondrial dysfunction and reduced healthspan. This suggests that fructose catabolism in the nervous system may contribute to neurodegeneration.
Key Genes Involved in GO:0006001 fructose catabolic process
The following genes encode enzymes and transporters directly involved in fructose catabolic process (GO:0006001).
| Gene | Major Role | Research Relevance |
|---|---|---|
| KHK | Phosphorylates fructose to fructose-1-phosphate | Rate-limiting enzyme; knockout models used to study fructose metabolism |
| ALDOB | Cleaves fructose-1-phosphate into glyceraldehyde and DHAP | Defects cause hereditary fructose intolerance |
| TKFC | Phosphorylates dihydroxyacetone to DHAP | Links fructose catabolism to glycolysis |
| PFKL | Phosphofructokinase, liver type | Regulates glycolytic flux downstream of fructose |
| G6PD | Glucose-6-phosphate dehydrogenase | Supports NADPH production from fructose-derived carbons |
| SLC2A5 | Fructose transporter GLUT5 | Mediates fructose uptake in intestine and other tissues |
| SLC2A2 | Glucose/fructose transporter GLUT2 | Facilitates fructose transport in liver and intestine |
| FBP1 | Fructose-1,6-bisphosphatase 1 | Gluconeogenic enzyme opposing glycolysis |
| ALDOA | Aldolase A | Glycolytic enzyme that can metabolize fructose intermediates |
| GAPDH | Glyceraldehyde-3-phosphate dehydrogenase | Glycolytic enzyme downstream of fructose catabolism |
| PKLR | Pyruvate kinase L/R | Regulates final steps of glycolysis from fructose |
| LDHA | Lactate dehydrogenase A | Converts fructose-derived pyruvate to lactate |
| ACACA | Acetyl-CoA carboxylase alpha | Drives lipogenesis from fructose-derived acetyl-CoA |
| FASN | Fatty acid synthase | Lipogenic enzyme induced by fructose catabolism |
| SCD1 | Stearoyl-CoA desaturase-1 | Lipogenic enzyme linked to fructose-induced steatosis |
| CPT1A | Carnitine palmitoyltransferase 1A | Regulates fatty acid oxidation, affected by fructose |
| NRF2 | Nuclear factor erythroid 2-related factor 2 | Redox regulator in fructose metabolism |
How Is fructose catabolic process Regulated?
Fructose catabolic process is regulated at multiple levels. In the intestine, fructose transport via SLC2A5 (GLUT5) and SLC2A2 (GLUT2) controls substrate availability. In the liver, fructokinase (KHK) activity is regulated by substrate supply and hormonal signals such as insulin. The pathway is also influenced by the redox state and energy charge of the cell, with AMPK and mTOR signaling integrating metabolic cues. In cancer, oncogenic signaling can upregulate fructose catabolism to support anabolic growth. Additionally, fructose catabolism is subject to feedback inhibition by downstream metabolites and is coordinated with gluconeogenesis via enzymes like FBP1.
fructose catabolic process and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| ALDOB | Hereditary fructose intolerance | Knockout or point-mutation in hepatocytes |
| KHK | Fructose-induced steatosis | Liver-specific knockout mice |
| SLC2A5 | Fructose malabsorption | Intestinal organoids with KO |
| TKFC | Cancer metabolism | Cancer cell lines with overexpression |
| FBP1 | Gluconeogenesis disorders | Knock-in of patient mutations |
Fructose catabolism and metabolic syndrome
Excessive fructose catabolism contributes to metabolic syndrome, including insulin resistance, dyslipidemia, and hypertension. High fructose intake overwhelms intestinal clearance, leading to hepatic fructose catabolism that drives de novo lipogenesis and steatosis. This process is a key link between dietary fructose and non-alcoholic fatty liver disease.
Fructose catabolism in cancer
Cancer cells reprogram fructose catabolism to support proliferation and survival. Fructose-derived carbons feed into nucleotide synthesis and maintain redox balance, making this pathway a potential target for cancer therapy. Inhibition of fructose catabolism may selectively starve cancer cells of essential metabolites.
Fructose catabolism and neurodegeneration
In neurons, excessive fructose catabolism impairs mitochondrial function and reduces healthspan. Studies in mouse motor neurons and C. elegans show that fructose exposure leads to mitochondrial dysfunction, suggesting a role in neurodegenerative diseases.
Hereditary fructose intolerance and malabsorption
Genetic defects in fructose catabolism, such as ALDOB deficiency, cause hereditary fructose intolerance, a severe disorder requiring strict fructose avoidance. Fructose malabsorption, often coexisting with sorbitol malabsorption, leads to gastrointestinal symptoms and is diagnosed by breath testing.
From fructose catabolic process-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does KHK knockout protect against fatty liver? | Liver-specific KHK knockout mouse |
| How does intestinal fructose catabolism affect systemic metabolism? | Intestine-specific SLC2A5 knockout mouse |
| Can ALDOB point mutations recapitulate hereditary fructose intolerance? | Hepatocyte knock-in of patient mutations |
| Does fructose catabolism support cancer growth? | Cancer cell lines with TKFC overexpression or knockout |
| What is the role of fructose catabolism in neurons? | C. elegans or mouse motor neurons with gene knockout |
| How does fructose catabolism regulate lipogenic genes? | Hepatocytes with tagged knock-in of FASN |
How to Study the fructose catabolic process Process
| Method | What It Measures | Typical Application |
|---|---|---|
| 13C-fructose tracing | Metabolic flux through fructose catabolism | Tissue-specific fructose metabolism |
| CRISPR knockout screen | Genes required for fructose catabolism | Cancer metabolism |
| RNA-seq | Transcriptional changes in fructose catabolism genes | Liver steatosis models |
| Proteomics | Protein abundance of enzymes | Metabolic syndrome |
| Seahorse assay | Mitochondrial respiration | Neuronal fructose toxicity |
| Breath test | Fructose malabsorption | Clinical diagnosis |
| Western blot | Enzyme expression and modification | Regulation studies |
| Immunofluorescence | Subcellular localization of enzymes | Tissue distribution |
Metabolic flux analysis
Isotope tracing with 13C-labeled fructose is used to quantify flux through fructose catabolic process in cells and tissues. This method identifies the fate of fructose-derived carbons and reveals tissue-specific differences.
CRISPR screens
Genome-wide CRISPR knockout screens can identify genes essential for fructose catabolism in cancer or metabolic cells. These screens link genotype to metabolic fitness and uncover novel regulators.
Transcriptomics and proteomics
RNA-seq and proteomics measure expression changes in enzymes and transporters of fructose catabolism under different conditions. These approaches reveal regulatory networks and biomarkers.
Mitochondrial function assays
Seahorse respirometry and mitochondrial membrane potential measurements assess the impact of fructose catabolism on mitochondrial function in neurons and other cells.
How CRISPR Can Be Used to Study GO:0006001 fructose catabolic process
Knockout
CRISPR knockout of KHK, ALDOB, or SLC2A5 in cell lines and animal models is used to block fructose catabolism and study its role in steatosis, cancer, and malabsorption. Knockout models help determine whether a gene is causally involved in fructose-induced phenotypes.
Point Mutation
Point mutations in ALDOB or KHK can recapitulate human hereditary fructose intolerance or alter enzyme activity. CRISPR point-mutation models allow precise testing of catalytic residues and regulatory sites.
Knock-in
Knock-in of tagged enzymes (e.g., HA-tagged KHK) enables tracking of protein localization and interactions during fructose catabolism. Knock-in of patient mutations provides disease models.
Overexpression
Overexpression of TKFC or GLUT5 in cancer cells enhances fructose catabolism and supports proliferation, allowing researchers to study metabolic reprogramming. Overexpression models are useful for identifying downstream effects.
How EDITGENE Supports fructose catabolic process Research
Researchers studying fructose catabolic process-related genes often need to determine whether a candidate gene is causally involved in metabolic phenotypes, disease progression, or therapeutic response. EDITGENE provides comprehensive CRISPR-based services to generate precisely engineered cell and animal models for such studies.
Contact EDITGENE today to design your custom CRISPR model for fructose catabolic process research.
Frequently Asked Questions About fructose catabolic process
What is fructose catabolic process?
Fructose catabolic process (GO:0006001) is the set of biochemical reactions that break down fructose into glucose, organic acids, and glycolytic intermediates.
What genes are involved in fructose catabolic process?
Key genes include KHK, ALDOB, TKFC, SLC2A5, and SLC2A2, which encode enzymes and transporters for fructose breakdown.
Where does fructose catabolism occur?
It occurs primarily in the small intestine and liver, with additional activity in kidney, adipose tissue, and neurons.
How is fructose catabolism regulated?
It is regulated by substrate availability, hormones like insulin, and signaling pathways such as AMPK and mTOR.
What diseases are linked to fructose catabolism?
Metabolic syndrome, fatty liver disease, cancer, neurodegeneration, and hereditary fructose intolerance are linked to altered fructose catabolism.
Why does fructose cause fatty liver?
Hepatic fructose catabolism bypasses the phosphofructokinase regulatory step, leading to unchecked lipogenesis and steatosis.
How does the small intestine affect fructose metabolism?
The small intestine converts most dietary fructose into glucose and organic acids, shielding the liver from excessive fructose.
Can CRISPR be used to study fructose catabolism?
Yes, CRISPR knockout, point mutation, knock-in, and overexpression models are used to dissect gene function in fructose catabolism.
What methods study fructose catabolic flux?
Isotope tracing, CRISPR screens, RNA-seq, proteomics, and mitochondrial assays are commonly used.
Is fructose catabolism a therapeutic target?
Yes, targeting fructose catabolism is being explored for metabolic syndrome, cancer, and neurodegeneration.
Conclusion
Fructose catabolic process (GO:0006001) is a fundamental metabolic pathway with profound implications for human health and disease. Its tissue-specific regulation, particularly in the small intestine and liver, determines systemic fructose handling and contributes to metabolic disorders. Dysregulated fructose catabolism is implicated in fatty liver disease, cancer, and neurodegeneration, making it a compelling target for therapeutic intervention. Advances in CRISPR-based models and metabolic flux analysis will continue to unravel the complexities of this pathway and guide the development of precision therapies.
References
- 1. Softic S et al.. 2016. Role of Dietary Fructose and Hepatic De Novo Lipogenesis in Fatty Liver Disease.. Dig Dis Sci 61(5):1282-93 PMID: 26856717
- 2. Jang C et al.. 2018. The Small Intestine Converts Dietary Fructose into Glucose and Organic Acids.. Cell Metab 27(2):351-361.e3 PMID: 29414685
- 3. Lodha D et al.. 2022. Detrimental effects of fructose on mitochondria in mouse motor neurons and on C. elegans healthspan.. Nutr Neurosci 25(6):1277-1286 PMID: 33258406
- 4. Krause N et al.. 2020. Fructose Metabolism in Cancer.. Cells 9(12) PMID: 33302403
- 5. Fernández-Bañares F et al.. 2009. Fructose-sorbitol malabsorption.. Curr Gastroenterol Rep 11(5):368-74 PMID: 19765364
- 6. Jang C et al.. 2020. The small intestine shields the liver from fructose-induced steatosis.. Nat Metab 2(7):586-593 PMID: 32694791
- 7. UNDERWOOD AH et al.. 1965. SOME PROPERTIES OF FRUCTOSE 1,6-DIPHOSPHATASE OF RAT LIVER AND THEIR RELATION TO THE CONTROL OF GLUCONEOGENESIS.. Biochem J 95(3):767-74 PMID: 14342513
- 8. Taskinen MR et al.. 2019. Dietary Fructose and the Metabolic Syndrome.. Nutrients 11(9) PMID: 31443567
